ANDA Submission Consulting

Accelerate ANDA Development with Regulatory Expertise and AI-Driven Efficiency

Successful ANDA submissions require more than technical documentation; they require regulatory strategy, submission excellence, and a deep understanding of FDA expectations.

ProPharma combines regulatory expertise with an AI-enabled submission platform to help generic drug sponsors streamline ANDA preparation, reduce operational burden, and accelerate submission readiness without compromising quality or compliance.

From first-time filers to established generic manufacturers, we provide the strategic guidance, technical expertise, and scalable support needed to move confidently from development to approval.

The ProPharma Difference: Expertise Enhanced by Innovation

Successful ANDA submissions require more than speed. They demand regulatory expertise, scientific rigor, and a clear understanding of FDA expectations.

Our proprietary approach to generic drug development combines experienced regulatory professionals with a novel AI-driven approach designed to improve efficiency without compromising quality. Our technology helps streamline document development, enhance consistency, and reduce manual effort, while our experts provide the strategic guidance, scientific review, and regulatory oversight needed to support submission success.

This expert-led, AI-enabled model helps sponsors:

• Accelerate submission timelines
• Improve consistency and quality across application components
• Reduce operational burden on internal teams
• Scale submission activities more efficiently
• Maintain confidence in regulatory compliance and submission readiness

Backed by former FDA professionals, CMC specialists, regulatory strategists, medical writers, and publishing experts, our team delivers the expertise and innovation needed to navigate ANDA submissions with greater speed.